Clinical Trial Update: Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravitreal bevacizumab for choroidal neovascularization secondary to age-related macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Instituto de Olhos de Goiania | Conditions: Age Related Macular Degeneration | Phase 4 | Status: COMPLETED